Hepatic Intra-Arterial Chemotherapy With Immunotherapy in NSCLC

Jose Carlos Benitez; Laura Mezquita; Rapahël Colle; Lambros Tselikas; Angela Botticella; Caroline Caramella; Benjamin Besse

doi:10.1016/j.jtho.2019.07.001

Hepatic Intra-Arterial Chemotherapy With Immunotherapy in NSCLC

Jose Carlos Benitez, Laura Mezquita, Rapahël Colle, Lambros Tselikas, Angela Botticella, Caroline Caramella, Benjamin Besse

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

Original language	English
Pages (from-to)	e215-e216
Journal	Journal of Thoracic Oncology
Volume	14
Issue number	10
DOIs	https://doi.org/10.1016/j.jtho.2019.07.001
Publication status	Published - 1 Oct 2019

Access to Document

10.1016/j.jtho.2019.07.001

Cite this

@article{4d0896477f79458499f5038cae4c5375,

title = "Hepatic Intra-Arterial Chemotherapy With Immunotherapy in NSCLC",

author = "Benitez, {Jose Carlos} and Laura Mezquita and Rapah{\"e}l Colle and Lambros Tselikas and Angela Botticella and Caroline Caramella and Benjamin Besse",

note = "Funding Information: Disclosure: Dr. Besse has received grants from Abbvie, Amgen, AstraZeneca, Biogen, Blueprint Medicines, Bristol-Myers Squibb, Celgene, Eli Lilly, GlaxoSmithKline, Ignyta, IPSEN, Merck KGaA, MSD, Nektar, Onxeo, Pfizer, PharmaMar, Sanofi, Spectrum Pharmaceuticals, Takeda, and Tiziana Pharma. The remaining authors declare no conflict of interest.",

year = "2019",

month = oct,

day = "1",

doi = "10.1016/j.jtho.2019.07.001",

language = "English",

volume = "14",

pages = "e215--e216",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

number = "10",

}

TY - JOUR

T1 - Hepatic Intra-Arterial Chemotherapy With Immunotherapy in NSCLC

AU - Benitez, Jose Carlos

AU - Mezquita, Laura

AU - Colle, Rapahël

AU - Tselikas, Lambros

AU - Botticella, Angela

AU - Caramella, Caroline

AU - Besse, Benjamin

N1 - Funding Information: Disclosure: Dr. Besse has received grants from Abbvie, Amgen, AstraZeneca, Biogen, Blueprint Medicines, Bristol-Myers Squibb, Celgene, Eli Lilly, GlaxoSmithKline, Ignyta, IPSEN, Merck KGaA, MSD, Nektar, Onxeo, Pfizer, PharmaMar, Sanofi, Spectrum Pharmaceuticals, Takeda, and Tiziana Pharma. The remaining authors declare no conflict of interest.

PY - 2019/10/1

Y1 - 2019/10/1

UR - http://www.scopus.com/inward/record.url?scp=85071439555&partnerID=8YFLogxK

U2 - 10.1016/j.jtho.2019.07.001

DO - 10.1016/j.jtho.2019.07.001

M3 - Article

C2 - 31302233

AN - SCOPUS:85071439555

SN - 1556-0864

VL - 14

SP - e215-e216

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 10

ER -

Hepatic Intra-Arterial Chemotherapy With Immunotherapy in NSCLC

Access to Document

Other files and links

Cite this